<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">16704343</PMID>
      <DateCompleted>
        <Year>2006</Year>
        <Month>12</Month>
        <Day>13</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2018</Year>
        <Month>11</Month>
        <Day>13</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">0066-4227</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>60</Volume>
            <PubDate>
              <Year>2006</Year>
            </PubDate>
          </JournalIssue>
          <Title>Annual review of microbiology</Title>
          <ISOAbbreviation>Annu Rev Microbiol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Francisella tularensis: taxonomy, genetics, and Immunopathogenesis of a potential agent of biowarfare.</ArticleTitle>
        <Pagination>
          <StartPage>167</StartPage>
          <EndPage>185</EndPage>
          <MedlinePgn>167-85</MedlinePgn>
        </Pagination>
        <Abstract>
          <AbstractText>Tularemia is a zoonosis of humans caused by infection with the facultative intracellular bacterium Francisella tularensis. Interest in F. tularensis has increased markedly in the past few years because of its potential use as an agent of bioterrorism. Five subspecies of this organism are found in the Northern hemisphere, but only F. tularensis subsp. tularensis and subsp. holarctica cause disease in humans. This review summarizes what is known about the pathogenesis of tularemia with a focus on bacterial surface components such as lipopolysaccharide and capsule as well as information obtained from the F. tularensis subsp. tularensis SCHU S4 genome. In particular, the mechanisms of action of recently identified virulence factors are discussed in the context of bacterial replication in macrophages and manipulation of the host inflammatory response. Throughout this report, shared and unique features of F. tularensis subsp. tularensis, subsp. holarctica, and subsp. novicida are discussed.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>McLendon</LastName>
            <ForeName>Molly K</ForeName>
            <Initials>MK</Initials>
            <AffiliationInfo>
              <Affiliation>Inflammation Program, Department of Microbiology, University of Iowa and the VA Medical Center, Iowa City, Iowa 52242, USA. molly-mclendon@uiowa.edu</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Apicella</LastName>
            <ForeName>Michael A</ForeName>
            <Initials>MA</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Allen</LastName>
            <ForeName>Lee-Ann H</ForeName>
            <Initials>LA</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>I01 BX000513</GrantID>
            <Acronym>BX</Acronym>
            <Agency>BLRD VA</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>P01 AI044642</GrantID>
            <Acronym>AI</Acronym>
            <Agency>NIAID NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>P01-AI044642</GrantID>
            <Acronym>AI</Acronym>
            <Agency>NIAID NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Annu Rev Microbiol</MedlineTA>
        <NlmUniqueID>0372370</NlmUniqueID>
        <ISSNLinking>0066-4227</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D016207">Cytokines</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D008070">Lipopolysaccharides</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016667" MajorTopicYN="N">Bacterial Capsules</DescriptorName>
          <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001694" MajorTopicYN="Y">Biological Warfare</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName>
          <QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005604" MajorTopicYN="N">Francisella tularensis</DescriptorName>
          <QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
          <QualifierName UI="Q000472" MajorTopicYN="Y">pathogenicity</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016680" MajorTopicYN="N">Genome, Bacterial</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008070" MajorTopicYN="N">Lipopolysaccharides</DescriptorName>
          <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009504" MajorTopicYN="N">Neutrophils</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010587" MajorTopicYN="N">Phagocytosis</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2006</Year>
          <Month>5</Month>
          <Day>18</Day>
          <Hour>9</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2006</Year>
          <Month>12</Month>
          <Day>14</Day>
          <Hour>9</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2006</Year>
          <Month>5</Month>
          <Day>18</Day>
          <Hour>9</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">16704343</ArticleId>
        <ArticleId IdType="mid">NIHMS16541</ArticleId>
        <ArticleId IdType="pmc">PMC1945232</ArticleId>
        <ArticleId IdType="doi">10.1146/annurev.micro.60.080805.142126</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Abd H, Johansson T, Golovliov I, Sandstrom G, Forsman M. Survival and growth of Francisella tularensis in Acanthamoeba castellanii. Appl Environ Microbiol. 2003;69:600–6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC152416</ArticleId>
            <ArticleId IdType="pubmed">12514047</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aderem A, Underhill DM. Mechanisms of phagocytosis in macrophages. Annu Rev Immunol. 1999;17:593–23.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10358769</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alibek K.  Biohazard: The Chilling True Story of the Largest Covert Biological Weapons Program in the World, Told From the Inside by the Man Who Ran It. New York: Random House; 1999. </Citation>
        </Reference>
        <Reference>
          <Citation>Ancuta P, Pedron T, Girard R, Sandstrom G, Chaby R. Inability of the Francisella tularensis lipopolysaccharide to mimic or to antagonize the induction of cell activation by endotoxins. Infect Immun. 1996;64:2041–46.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC174034</ArticleId>
            <ArticleId IdType="pubmed">8675305</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Anthony LD, Burke RD, Nano FE. Growth of Francisella spp. in rodent macrophages. Infect Immun. 1991;59:3291–96.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC258167</ArticleId>
            <ArticleId IdType="pubmed">1879943</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Anthony LS, Cowley SC, Mdluli KE, Nano FE. Isolation of a Francisella tularensis mutant that is sensitive to serum and oxidative killing and is avirulent in mice: correlation with the loss of MinD homologue expression. FEMS Microbiol Lett. 1994;124:157–65.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7813885</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Anthony LS, Ghadirian E, Nestel FP, Kongshavn PA. The requirement for gamma interferon in resistance of mice to experimental tularemia. Microb Pathog. 1989;7:421–28.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2516219</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Anthony LS, Gu MZ, Cowley SC, Leung WW, Nano FE. Transformation and allelic replacement in Francisella spp. J Gen Microbiol. 1991;137:2697–703.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1791425</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Anthony LS, Morrissey PJ, Nano FE. Growth inhibition of Francisella tularensis live vaccine strain by IFN-gamma-activated macrophages is mediated by reactive nitrogen intermediates derived from l-arginine metabolism. J Immunol. 1992;148:1829–34.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1541823</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bailey KC.  Directors Series on Proliferation. Springfield, VA: Lawrence Livermore Natl. Lab; 1994. </Citation>
        </Reference>
        <Reference>
          <Citation>Baron GS, Myltseva SV, Nano FE. Electroporation of Francisella tularensis. Methods Mol Biol. 1995;47:149–54.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7550729</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baron GS, Nano FE. MglA and MglB are required for the intramacrophage growth of Francisella novicida. Mol Microbiol. 1998;29:247–59.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9701818</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baron GS, Reilly TJ, Nano FE. The respiratory burst-inhibiting acid phosphatase AcpA is not essential for the intramacrophage growth or virulence of Francisella novicida. FEMS Microbiol Lett. 1999;176:85–90.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10418134</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Berdal BP, Mehl R, Meidell NK, Lorentzen-Styr AM, Scheel O. Field investigations of tularemia in Norway. FEMS Immunol Med Microbiol. 1996;13:191–95.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8861027</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Berg JM, Mdluli KE, Nano FE. Molecular cloning of the recA gene and construction of a recA strain of Francisella novicida. Infect Immun. 1992;60:690–93.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC257686</ArticleId>
            <ArticleId IdType="pubmed">1309722</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bolger CE, Forestal CA, Italo JK, Benach JL, Furie MB. The live vaccine strain of Francisella tularensis replicates in human and murine macrophages but induces only the human cells to secrete proinflammatory cytokines. J Leukoc Biol. 2005;77:893–97.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15758077</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bosio CM, Dow SW. Francisella tularensis induces aberrant activation of pulmonary dendritic cells. J Immunol. 2005;175:6792–801.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16272336</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bosio CM, Elkins KL. Susceptibility to secondary Francisella tularensis live vaccine strain infection in B-cell-deficient mice is associated with neutrophilia but not with defects in specific T-cell-mediated immunity. Infect Immun. 2001;69:194–203.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC97872</ArticleId>
            <ArticleId IdType="pubmed">11119506</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Broekhuijsen M, Larsson P, Johansson A, Bystrom M, Eriksson U, et al.  Genome-wide DNA microarray analysis of Francisella tularensis strains demonstrates extensive genetic conservation within the species but identifies regions that are unique to the highly virulent F. tularensis subsp. tularensis. J Clin Microbiol. 2003;41:2924–31.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC165330</ArticleId>
            <ArticleId IdType="pubmed">12843022</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Burrows LL. Weapons of mass retraction. Mol Microbiol. 2005;57:878–88.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16091031</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Caroff M, Karibian D. Structure of bacterial lipopolysaccharides. Carbohydr Res. 2003;338:2431–47.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14670707</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Centers for Disease Control. Summary of notifiable diseases, United States, 2001. MMWR Morb Mortal Wkly Rep. 2001;50:1–108.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12892074</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen I, Dubnau D. DNA transformation during transformation. Front Biosci. 2003;8:s544–56.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12700070</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen W, KuoLee R, Shen H, Busa M, Conlan JW. Toll-like receptor 4 (TLR4) does not confer a resistance advantage on mice against low-dose aerosol infection with virulent type A Francisella tularensis. Microb Pathog. 2004;37:185–91.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15458779</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen W, Kuolee R, Shen H, Busa M, Conlan JW. Toll-like receptor 4 (TLR4) plays a relatively minor role in murine defense against primary intradermal infection with Francisella tularensis LVS. Immunol Lett. 2005;97:151–54.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15626487</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen W, Kuolee RK, Austin JW, Shen H, Che Y, Conlan JW. Low dose aerosol infection of mice with virulent type A Francisella tularensis induces severe thymus atrophy and CD4+ CD8+ thymocyte depletion. Microb Pathog. 2005;39:189–96.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1564440</ArticleId>
            <ArticleId IdType="pubmed">16257504</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cherwonogrodzky JW, Knodel MH, Spence MR. Increased encapsulation and virulence of Francisella tularensis live vaccine strain (LVS) by subculturing on synthetic medium. Vaccine. 1994;12:773–75.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7975855</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Christopher GW, Cieslak TJ, Pavlin JA, Eitzen EMJ. Biological warfare. A historical perspective. JAMA. 1997;278:412–17.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9244333</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clemens DL, Lee BY, Horwitz MA. Virulent and avirulent strains of Francisella tularensis prevent acidification and maturation of their phagosomes and escape into the cytoplasm in human macrophages. Infect Immun. 2004;72:3204–17.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC415696</ArticleId>
            <ArticleId IdType="pubmed">15155622</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clemens DL, Lee BY, Horwitz MA. Francisella tularensis enters macrophages via a novel process involving pseudopod loops. Infect Immun. 2005;73:5892–902.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1231130</ArticleId>
            <ArticleId IdType="pubmed">16113308</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Conlan JW, KuoLee R, Shen H, Webb A. Different host defences are required to protect mice from primary systemic vs pulmonary infection with the facultative intracellular bacterial pathogen, Francisella tularensis LVS. Microb Pathog. 2002;32:127–34.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11855943</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Conlan JW, North RJ. Early pathogenesis of infection in the liver with the facultative intracellular bacteria Listeria monocytogenes, Francisella tularensis, and Salmonella typhimurium involves lysis of infected hepatocytes by leukocytes. Infect Immun. 1992;60:5164–71.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC258293</ArticleId>
            <ArticleId IdType="pubmed">1452350</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Conlan JW, Sjostedt A, North RJ. CD4+ and CD8+ T-cell-dependent and -independent host defense mechanisms can operate to control and resolve primary and secondary Francisella tularensis LVS infection in mice. Infect Immun. 1994;62:5603–7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC303308</ArticleId>
            <ArticleId IdType="pubmed">7960142</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cowley SC, Elkins KL. Multiple T cell subsets control Francisella tularensis LVS intracellular growth without stimulation through macrophage interferon gamma receptors. J Exp Med. 2003;198:379–89.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2194083</ArticleId>
            <ArticleId IdType="pubmed">12885873</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cowley SC, Gray CJ, Nano FE. Isolation and characterization of Francisella novicida mutants defective in lipopolysaccharide biosynthesis. FEMS Microbiol Lett. 2000;182:63–67.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10612732</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cowley SC, Myltseva SV, Nano FE. Phase variation in Francisella tularensis affecting intracellular growth, lipopolysaccharide antigenicity and nitric oxide production. Mol Microbiol. 1996;20:867–74.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8793882</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cowley SC, Myltseva SV, Nano FE. Suppression of Francisella tularensis growth in the rat by coinfection with F. novicida. FEMS Microbiol Lett. 1997;153:71–74.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9252574</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Croddy E, Krcalova S. Tularemia, biological warfare, and the battle for Stalingrad (1942–1943) Mil Med. 2001;166:837–38.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11603230</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Culkin SJ, Rhinehart-Jones T, Elkins KL. A novel role for B cells in early protective immunity to an intracellular pathogen, Francisella tularensis strain LVS. J Immunol. 1997;158:3277–84.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9120284</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dahlstrand S, Ringertz O, Zetterberg B. Airborne tularemia in Sweden. Scand J Infect Dis. 1971;3:7–16.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">5099427</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dennis DT, Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, et al.  Tularemia as a biological weapon: medical and public health management. JAMA. 2001;285:2763–73.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11386933</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Duckett NS, Olmos S, Durrant DM, Metzger DW. Intranasal interleukin-12 treatment for protection against respiratory infection with the Francisella tularensis live vaccine strain. Infect Immun. 2005;73:2306–11.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1087453</ArticleId>
            <ArticleId IdType="pubmed">15784575</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Elkins KL, Bosio CM, Rhinehart-Jones TR. Importance of B cells, but not specific antibodies, in primary and secondary protective immunity to the intracellular bacterium Francisella tularensis live vaccine strain. Infect Immun. 1999;67:6002–7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC96986</ArticleId>
            <ArticleId IdType="pubmed">10531260</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Elkins KL, Cooper A, Colombini SM, Cowley SC, Kieffer TL. In vivo clearance of an intracellular bacterium, Francisella tularensis LVS, is dependent on the p40 subunit of interleukin-12 (IL-12) but not on IL-12 p70. Infect Immun. 2002;70:1936–48.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC127864</ArticleId>
            <ArticleId IdType="pubmed">11895957</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Elkins KL, Rhinehart-Jones TR, Culkin SJ, Yee D, Winegar RK. Minimal requirements for murine resistance to infection with Francisella tularensis LVS. Infect Immun. 1996;64:3288–93.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC174220</ArticleId>
            <ArticleId IdType="pubmed">8757866</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Farlow J, Smith KL, Wong J, Abrams M, Lytle M, Keim P. Francisella tularensis strain typing using multiple-locus, variable-number tandem repeat analysis. J Clin Microbiol. 2001;39:3186–92.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC88316</ArticleId>
            <ArticleId IdType="pubmed">11526148</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Forestal CA, Benach JL, Carbonara C, Italo JK, Lisinski TJ, Furie MB. Francisella tularensis selectively induces proinflammatory changes in endothelial cells. J Immunol. 2003;171:2563–70.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12928407</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Forsman M, Sandstrom G, Sjostedt A. Analysis of 16S ribosomal DNA sequences of Francisella strains and utilization for determination of the phylogeny of the genus and for identification of strains by PCR. Int J Syst Bacteriol. 1994;44:38–46.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8123561</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fortier AH, Leiby DA, Narayanan RB, Asafoadjei E, Crawford RM, et al.  Growth of Francisella tularensis LVS in macrophages: The acidic intracellular compartment provides essential iron required for growth. Infect Immun. 1995;63:1478–83.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC173178</ArticleId>
            <ArticleId IdType="pubmed">7890413</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fortier AH, Polsinelli T, Green SJ, Nacy CA. Activation of macrophages for destruction of Francisella tularensis: identification of cytokines, effector cells, and effector molecules. Infect Immun. 1992;60:817–25.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC257560</ArticleId>
            <ArticleId IdType="pubmed">1541555</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Francis E. Sources of infection and seasonal incidence of tularemia in man. Public Health Rep. 1937;52:103–13.</Citation>
        </Reference>
        <Reference>
          <Citation>Fulop M, Mastroeni P, Green M, Titball RW. Role of antibody to lipopolysaccharide in protection against low- and high-virulence strains of Francisella tularensis. Vaccine. 2001;19:4465–72.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11483272</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gao LY, Abu Kwaik Y. Hijacking of apoptotic pathways by bacterial pathogens. Microbes Infect. 2000;2:1705–19.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11137044</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gil H, Benach JL, Thanassi DG. Presence of pili on the surface of Francisella tularensis. Infect Immun. 2004;72:3042–47.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC387894</ArticleId>
            <ArticleId IdType="pubmed">15102818</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gioannini TL, Teghanemt A, Zhang DS, Coussens NP, Dockstader W, et al.  Isolation of an endotoxin-MD-2 complex that produces Toll-like receptor 4-dependent cell activation at picomolar concentrations. Proc Natl Acad Sci USA. 2004;101:4186–91.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC384716</ArticleId>
            <ArticleId IdType="pubmed">15010525</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Golovliov I, Baranov V, Krocova Z, Kovarova H, Sjostedt A. An attenuated strain of the facultative intracellular bacterium Francisella tularensis can escape the phagosome of monocytic cells. Infect Immun. 2003;71:5940–50.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC201066</ArticleId>
            <ArticleId IdType="pubmed">14500514</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Golovliov I, Ericsson M, Sandstrom G, Tarnvik A, Sjostedt A. Identification of proteins of Francisella tularensis induced during growth in macrophages and cloning of the gene encoding a prominently induced 23-kDa protein. Infect Immun. 1997;65:2183–89.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC175301</ArticleId>
            <ArticleId IdType="pubmed">9169749</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Golovliov I, Sandstrom G, Ericsson M, Sjostedt A, Tarnvik A. Cytokine expression in the liver during the early phase of murine tularemia. Infect Immun. 1995;63:534–38.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC173028</ArticleId>
            <ArticleId IdType="pubmed">7822019</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Golovliov I, Sjostedt A, Mokrievich A, Pavlov V. A method for allelic replacement in Francisella tularensis. FEMS Microbiol Lett. 2003;222:273–80.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12770718</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gray CG, Cowley SC, Cheung KK, Nano FE. The identification of five genetic loci of Francisella novicida associated with intracellular growth. FEMS Microbiol Lett. 2002;215:53–56.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12393200</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Green SJ, Nacy CA, Schreiber RD, Granger DL, Crawford RM, et al.  Neutralization of gamma interferon and tumor necrosis factor alpha blocks in vivo synthesis of nitrogen oxides from l-arginine and protection against Francisella tularensis infection in Mycobacterium bovis BCG-treated mice. Infect Immun. 1993;61:689–98.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC302781</ArticleId>
            <ArticleId IdType="pubmed">8423095</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Green SJ, Scheller LF, Marletta MA, Seguin MC, Klotz FW, et al.  Nitric oxide: cytokine-regulation of nitric oxide in host resistance to intracellular pathogens. Immunol Lett. 1994;43:87–94.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7537721</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Harris R, Paxman J.  A Higher Form of Killing. New York: Hill &amp; Wang; 1982. p. 74.</Citation>
        </Reference>
        <Reference>
          <Citation>Harris S. Japanese biological warfare research on humans: a case study of microbiology and ethics. Ann N Y Acad Sci. 1992;666:21–52.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1297279</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hartley G, Taylor R, Prior R, Newstead S, Hitchen PG, et al.  Grey variants of the live vaccine strain of Francisella tularensis lack lipopolysaccharide O-antigen, show reduced ability to survive in macrophages and do not induce protective immunity in mice. Vaccine. 2006;24:989–96.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16257097</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hollis DG, Weaver RE, Steigerwalt AG, Wenger JD, Moss CW, Brenner DJ. Francisella philomiragia comb. nov (formerly Yersinia philomiragia) and Francisella tularensis biogroup novicida (formerly Francisella novicida) associated with human disease . J Clin Microbiol. 1989;27:1601–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC267622</ArticleId>
            <ArticleId IdType="pubmed">2671019</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hood AM. Virulence factors of Francisella tularensis. J Hyg. 1977;79:47–60.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2129918</ArticleId>
            <ArticleId IdType="pubmed">267668</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jellison WL, Kohls GM. Tularemia in sheep and sheep industry workers in western United States. Public Health Serv. 1955:17.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">13254983</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Karpov SP. The spread of tularemia through water as a new factor in its epidemiology. J Bacteriol. 1936;32:243–58.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC543788</ArticleId>
            <ArticleId IdType="pubmed">16559947</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kawula TH, Hall JD, Fuller JR, Craven RR. Use of transposon-transposase complexes to create stable insertion mutant strains of Francisella tularensis LVS. Appl Environ Microbiol. 2004;70:6901–4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC525197</ArticleId>
            <ArticleId IdType="pubmed">15528561</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kieffer TL, Cowley S, Nano FE, Elkins KL. Francisella novicida LPS has greater immunobiological activity in mice than F. tularensis LPS, and contributes to F. novicida murine pathogenesis. Microbes Infect. 2003;5:397–403.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12737995</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kuoppa K, Forsberg A, Norqvist A. Construction of a reporter plasmid for screening in vivo promoter activity in Francisella tularensis. FEMS Microbiol Lett. 2001;205:77–81.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11728719</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lai XH, Golovliov I, Sjostedt A. Francisella tularensis induces cytopathogenicity and apoptosis in murine macrophages via a mechanism that requires intracellular bacterial multiplication. Infect Immun. 2001;69:4691–94.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC98551</ArticleId>
            <ArticleId IdType="pubmed">11402018</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lai XH, Golovliov I, Sjostedt A. Expression of IglC is necessary for intracellular growth and induction of apoptosis in murine macrophages by Francisella tularensis. Microb Pathog. 2004;37:225–30.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15519043</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lai XH, Sjostedt A. Delineation of the molecular mechanisms of Francisella tularensis-induced apoptosis in murine macrophages. Infect Immun. 2003;71:4642–46.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC165996</ArticleId>
            <ArticleId IdType="pubmed">12874344</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Larsson P, Oyston PC, Chain P, Chu MC, Duffield M, et al.  The complete genome sequence of Francisella tularensis, the causative agent of tularemia. Nat Genet. 2005;37:153–59.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15640799</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lauriano CM, Barker JR, Yoon SS, Nano FE, Arulanandam BP, et al.  MglA regulates transcription of virulence factors necessary for Francisella tularensis intraamoebae and intramacrophage survival. Proc Natl Acad Sci USA. 2004;101:4246–49.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC384726</ArticleId>
            <ArticleId IdType="pubmed">15010524</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Leiby DA, Fortier AH, Crawford RM, Schreiber RD, Nacy CA. In vivo modulation of the murine immune response to Francisella tularensis LVS by administration of anticytokine antibodies. Infect Immun. 1992;60:84–89.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC257506</ArticleId>
            <ArticleId IdType="pubmed">1729199</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lesho E, Dorsey D, Bunner D. Feces, dead horses, and fleas: evolution of the hostile use of biological agents. West J Med. 1998;168:512–16.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1305067</ArticleId>
            <ArticleId IdType="pubmed">9655992</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lindgren H, Golovliov I, Baranov V, Ernst RK, Telepnev M, Sjostedt A. Factors affecting the escape of Francisella tularensis from the phagolysosome. J Med Microbiol. 2004;53:953–58.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15358816</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lindgren H, Stenmark S, Chen W, Tarnvik A, Sjostedt A. Distinct roles of reactive nitrogen and oxygen species to control infection with the facultative intracellular bacterium Francisella tularensis. Infect Immun. 2004;72:7172–82.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC529105</ArticleId>
            <ArticleId IdType="pubmed">15557642</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lofgren S, Tarnvik A, Bloom GD, Sjoberg W. Phagocytosis and killing of Francisella tularensis by human polymorphonuclear leukocytes. Infect Immun. 1983;39:715–20.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC348008</ArticleId>
            <ArticleId IdType="pubmed">6832815</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lofgren S, Tarnvik A, Carlsson J. Demonstration of opsonizing antibodies to Francisella tularensis by leukocyte chemiluminescence. Infect Immun. 1980;29:329–34.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC551121</ArticleId>
            <ArticleId IdType="pubmed">7216416</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lofgren S, Tarnvik A, Thore M, Carlsson J. A wild and an attenuated strain of Francisella tularensis differ in susceptibility to hypochlorous acid: a possible explanation of their different handling by polymorphonuclear leukocytes. Infect Immun. 1984;43:730–34.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC264361</ArticleId>
            <ArticleId IdType="pubmed">6319290</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maier TM, Havig A, Casey M, Nano FE, Frank DW, Zahrt TC. Construction and characterization of a highly efficient Francisella shuttle plasmid. Appl Environ Microbiol. 2004;70:7511–19.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC535190</ArticleId>
            <ArticleId IdType="pubmed">15574954</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mariathasan S, Weiss DS, Dixit VM, Monack DM. Innate immunity against Francisella tularensis is dependent on the ASC/caspase-1 axis. J Exp Med. 2005;202:1043–49.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2213215</ArticleId>
            <ArticleId IdType="pubmed">16230474</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McCoy GW, Chapin CW. Further observations on a plague-like diseases of rodents with a preliminary note on the causative agent, Bacterium tularensis. J Infect Dis. 1912;10:61–72.</Citation>
        </Reference>
        <Reference>
          <Citation>McDonald MK, Cowley SC, Nano FE. Temperature-sensitive lesions in the Francisella novicida valA gene cloned into an Escherichia coli msbA lpxK mutant affecting deoxycholate resistance and lipopolysaccharide assembly at the restrictive temperature. J Bacteriol. 1997;179:7638–43.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC179724</ArticleId>
            <ArticleId IdType="pubmed">9401020</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mdluli KE, Anthony LS, Baron GS, McDonald MK, Myltseva SV, Nano FE. Serum-sensitive mutation of Francisella novicida: association with an ABC transporter gene. Microbiology. 1994;140:3309–18.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7881549</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nano FE, Zhang N, Cowley SC, Klose KE, Cheung KK, et al.  A Francisella tularensis pathogenicity island required for intramacrophage growth. J Bacteriol. 2004;186:6430–36.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC516616</ArticleId>
            <ArticleId IdType="pubmed">15375123</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nauseef WM. Contributions of myeloperoxidase to proinflammatory events: more than an antimicrobial system. Int J Hematol. 2001;74:125–33.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11594511</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nauseef WM. Assembly of the phagocyte NADPH oxidase. Histochem Cell Biol. 2004;122:277–91.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15293055</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Norqvist A, Kuoppa K, Sandstrom G. Construction of a shuttle vector for use in Francisella tularensis. FEMS Immunol Med Microbiol. 1996;13:257–60.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8861040</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nudleman E, Kaiser D. Pulling together with type IV pili. J Mol Microbiol Biotechnol. 2004;7:52–62.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15170403</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pavlov VM, Mokrievich AN, Volkovoy K. Cryptic plasmid pFNL10 from Francisella novicida-like F6168: the base of plasmid vectors for Francisella tularensis. FEMS Immunol Med Microbiol. 1996;13:253–56.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8861039</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Penn RL.  Francisella tularensis (tularemia) In: Mandell GL, Bennett JE, Dolin R, editors. Principles and Practice of Infectious Diseases. 6 New York: Churchill Livingstone; 2005. pp. 2674–85.</Citation>
        </Reference>
        <Reference>
          <Citation>Phillips NJ, Schilling B, McLendon MK, Apicella MA, Gibson BW. Novel modification of lipid A of Francisella tularensis. Infect Immun. 2004;72:5340–48.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC517411</ArticleId>
            <ArticleId IdType="pubmed">15322031</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Polsinelli T, Meltzer MS, Fortier AH. Nitric oxide-independent killing of Francisella tularensis by IFN-gamma-stimulated murine alveolar macrophages. J Immunol. 1994;153:1238–45.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8027551</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pomerantsev AP, Obuchi M, Ohara Y. Nucleotide sequence, structural organization, and functional characterization of the small recombinant plasmid pOM1 that is specific for Francisella tularensis. Plasmid. 2001;46:86–94.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11591134</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Prior JL, Prior RG, Hitchen PG, Diaper H, Griffin KF, et al.  Characterization of the O antigen gene cluster and structural analysis of the O antigen of Francisella tularensis subsp tularensis. J Med Microbiol. 2003;52:845–51.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12972577</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Proctor RA, White JD, Ayala E, Canonico PG. Phagocytosis of Francisella tularensis by Rhesus monkey peripheral leukocytes. Infect Immun. 1975;11:146–51.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC415038</ArticleId>
            <ArticleId IdType="pubmed">234911</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Raetz CR, Whitfield C. Lipopolysaccharide endotoxins. Annu Rev Biochem. 2002;71:635–700.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2569852</ArticleId>
            <ArticleId IdType="pubmed">12045108</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Reilly TJ, Baron GS, Nano FE, Kuhlenschmidt MS. Characterization and sequencing of a respiratory burst-inhibiting acid phosphatase from Francisella tularensis. J Biol Chem. 1996;271:10973–83.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8631917</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Report of a WHO Group of Consultants. Health Aspects of Chemical and Biological Weapons. Geneva, Switzerland: World Health Org; 1970. p. 132.</Citation>
        </Reference>
        <Reference>
          <Citation>Sandstrom G, Lofgren S, Tarnvik A. A capsule-deficient mutant of Francisella tularensis LVS exhibits enhanced sensitivity to killing by serum but diminished sensitivity to killing by polymorphonuclear leukocytes. Infect Immun. 1988;56:1194–202.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC259783</ArticleId>
            <ArticleId IdType="pubmed">3356465</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sandstrom G, Sjostedt A, Johansson T, Kuoppa K, Williams JC. Immunogenicity and toxicity of lipopolysaccharide from Francisella tularensis LVS. FEMS Microbiol Immunol. 1992;5:201–10.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1419118</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Santic M, Molmeret M, Abu Kwail Y. Modulation of biogenesis of the Francisella tularensis subsp novicida-containing phagosome in quiescent human macrophages and its maturation into a phagolysosome upon activation by IFN-γ. Cell Microbiol. 2005;7:957–67.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15953028</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Santic M, Molmeret M, Klose KE, Jones S, Abu Kwail Y. The Francisella tularensis pathogenicity island protein IglC and its regulator MglA are essential for modulating phagosome biogenesis and subsequent bacterial escape into the cytoplasm. Cell Microbiol. 2005;7:969–79.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15953029</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Saslaw S, Eigelsbach HT, Prior JA, Wilson HE, Carhart S. Tularemia vaccine study. II Respiratory challenge. Arch Intern Med. 1961;107:702–14.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">13746667</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Saslaw S, Eigelsbach HT, Wilson HE, Prior JA, Carhart S. Tularemia vaccine study. I Intracutaneous challenge. Arch Intern Med. 1961;107:689–701.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">13746668</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sjostedt A, Conlan JW, North RJ. Neutrophils are critical for host defense against primary infection with the facultative intracellular bacterium Francisella tularensis in mice and participate in defense against reinfection. Infect Immun. 1994;62:2779–83.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC302881</ArticleId>
            <ArticleId IdType="pubmed">8005668</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sorokin VM, Pavlovich NV, Prozorova LA. Francisella tularensis resistance to bactericidal action of normal human serum. FEMS Immunol Med Microbiol. 1996;13:249–52.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8861038</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Svensson K, Larsson P, Johansson D, Bystrom M, Forsman M, Johansson A. Evolution of subspecies of Francisella tularensis. J Bacteriol. 2005;187:3903–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1112057</ArticleId>
            <ArticleId IdType="pubmed">15901721</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Takafuji ET.  Biological Weapons and Modern Warfare. Washington, DC: Ind. Coll. Armed Forces, Natl. Def. Univ., Ft. McNair; 1991. </Citation>
        </Reference>
        <Reference>
          <Citation>Tarnvik A. Nature of protective immunity to Francisella tularensis. Rev Infect Dis. 1989;11:440–51.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2665002</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Teghanemt A, Zhang DS, Levis EN, Weiss JP, Gioannini TL. Molecular basis of reduced potency of underacylated endotoxins. J Immunol. 2005;175:4669–76.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16177114</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Telepnev M, Golovliov I, Grundstrom T, Tarnvik A, Sjostedt A. Francisella tularensis inhibits Toll-like receptor-mediated activation of intracellular signaling and secretion of TNF-alpha and IL-1 from murine macrophages. Cell Microbiol. 2003;5:41–51.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12542469</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Telepnev M, Golovilov I, Sjostedt A. Francisella tularensis LVS initially activates but subsequently down-regulates intracellular signaling and cytokine secretion in mouse monocytic and human peripheral blood mononuclear cells. Microb Pathog. 2005;38:239–47.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15925273</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thirumalapura NR, Goad DW, Mort A, Morton RJ, Clarke J, Malayer J. Structural analysis of the O-antigen of Francisella tularensis subspecies tularensis strain OSU 10. J Med Microbiol. 2005;54:693–95.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15947437</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thomas R, Johansson A, Neeson B, Isherwood K, Sjostedt A, et al.  Discrimination of human pathogenic subspecies of Francisella tularensis by using restriction fragment length polymorphism. J Clin Microbiol. 2003;41:50–57.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC149632</ArticleId>
            <ArticleId IdType="pubmed">12517824</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thomassen MJ, Kavuru MS. Human alveolar macrophages and monocytes as a source and target for nitric oxide. Int Immunopathol. 2001;1:1479–90.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11515813</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Twine S, Bystrom M, Chen W, Forsman M, Golovliov I, et al.  A mutant of Francisella tularensis strain SCHU S4 lacking the ability to express a 58-kilodalton protein is attenuated for virulence and is an effective live vaccine. Infect Immun. 2005;73:8345–52.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1307091</ArticleId>
            <ArticleId IdType="pubmed">16299332</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tyeryar FJJ, Lawton WD. Transformation of Pasteurella novicida. J Bacteriol. 1969;100:1112–13.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC250201</ArticleId>
            <ArticleId IdType="pubmed">5359612</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vinogradov E, Perry MB. Characterization of the core part of the lipopolysaccharide O-antigen of Francisella novicida (U112) Carbohydr Res. 2004;339:1643–48.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15183739</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vinogradov E, Perry MB, Conlan JW. Structural analysis of Francisella tularensis lipopolysaccharide. Eur J Biochem. 2002;269:6112–18.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12473106</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vinogradov EV, Shashkov AS, Knirel YA, Kochetkov NK, Tochtamysheva NV, et al.  Structure of the O-antigen of Francisella tularensis strain 15. Carbohydr Res. 1991;214:289–97.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1769021</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang X, Karbarz MJ, McGrath SC, Cotter RJ, Raetz CR. MsbA transporter-dependent lipid A 1-dephosphorylation on the periplasmic surface of the inner membrane: topography of Francisella novicida LpxE expressed in Escherichia coli. J Biol Chem. 2004;279:49470–78.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2552400</ArticleId>
            <ArticleId IdType="pubmed">15339914</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yee D, Rhinehart-Jones TR, Elkins KL. Loss of either CD4+ or CD8+ T cells does not affect the magnitude of protective immunity to an intracellular pathogen, Francisella tularensis strain LVS. J Immunol. 1996;157:5042–48.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8943413</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
